Beitler JR, Thompson BT, Baron RM, Bastarache JA, Denlinger LC, Esserman L, Gong MN, LaVange LM, Lewis RJ, Marshall JC, Martin TR, McAuley DF, Meyer NJ, Moss M, Reineck LA, Rubin E, Schmidt EP, Standiford TJ, Ware LB, Wong HR, Aggarwal NR, Calfee CS (2022) Advancing precision medicine for acute respiratory distress syndrome. Lancet Respir Med 10(1):107–120. https://doi.org/10.1016/s2213-2600(21)00157-0

CAS  Article  PubMed  Google Scholar 

Bettaieb A, Nagata N, AbouBechara D, Chahed S, Morisseau C, Hammock BD, Haj FG (2013) Soluble epoxide hydrolase deficiency or inhibition attenuates diet-induced endoplasmic reticulum stress in liver and adipose tissue. J Biol Chem 288(20):14189–14199. https://doi.org/10.1074/jbc.M113.458414

CAS  Article  PubMed  PubMed Central  Google Scholar 

Chen Z, Tang Y, Yu J, Dong R, Yang Y, Fu M, Luo J, Hu S, Wang DW, Tu L, Xu X (2020) sEH inhibitor tppu ameliorates cecal ligation and puncture-induced sepsis by regulating macrophage functions. Shock 53(6):761–771. https://doi.org/10.1097/shk.0000000000001408

CAS  Article  PubMed  PubMed Central  Google Scholar 

Dong R, Hu D, Yang Y, Chen Z, Fu M, Wang DW, Xu X, Tu L (2017) EETs reduces LPS-induced hyperpermeability by targeting GRP78 mediated Src activation and subsequent Rho/ROCK signaling pathway. Oncotarget 8(31):50958–50971. https://doi.org/10.18632/oncotarget.17331

Article  PubMed  PubMed Central  Google Scholar 

Ferrer MD, Busquets-Cortés C, Capó X, Tejada S, Tur JA, Pons A, Sureda A (2019) Cyclooxygenase-2 inhibitors as a therapeutic target in inflammatory diseases. Curr Med Chem 26(18):3225–3241. https://doi.org/10.2174/0929867325666180514112124

CAS  Article  PubMed  Google Scholar 

Gartung A, Yang J, Sukhatme VP, Bielenberg DR, Fernandes D, Chang J, Schmidt BA, Hwang SH, Zurakowski D, Huang S, Kieran MW, Hammock BD, Panigrahy D (2019) Suppression of chemotherapy-induced cytokine/lipid mediator surge and ovarian cancer by a dual COX-2/sEH inhibitor. Proc Natl Acad Sci U S A 116(5):1698–1703. https://doi.org/10.1073/pnas.1803999116

CAS  Article  PubMed  PubMed Central  Google Scholar 

Harris TR, Hammock BD (2013) Soluble epoxide hydrolase: gene structure, expression and deletion. Gene 526(2):61–74. https://doi.org/10.1016/j.gene.2013.05.008

CAS  Article  PubMed  PubMed Central  Google Scholar 

Harris TR, Bettaieb A, Kodani S, Dong H, Myers R, Chiamvimonvat N, Haj FG, Hammock BD (2015) Inhibition of soluble epoxide hydrolase attenuates hepatic fibrosis and endoplasmic reticulum stress induced by carbon tetrachloride in mice. Toxicol Appl Pharmacol 286(2):102–111. https://doi.org/10.1016/j.taap.2015.03.022

CAS  Article  PubMed  PubMed Central  Google Scholar 

Hooijmans CR, Rovers MM, de Vries RB, Leenaars M, Ritskes-Hoitinga M, Langendam MW (2014) SYRCLE’s risk of bias tool for animal studies. BMC Med Res Methodol 14:43. https://doi.org/10.1186/1471-2288-14-43

Article  PubMed  PubMed Central  Google Scholar 

Inceoglu B, Bettaieb A, Haj FG, Gomes AV, Hammock BD (2017) Modulation of mitochondrial dysfunction and endoplasmic reticulum stress are key mechanisms for the wide-ranging actions of epoxy fatty acids and soluble epoxide hydrolase inhibitors. Prostaglandins Other Lipid Mediat 133:68–78. https://doi.org/10.1016/j.prostaglandins.2017.08.003

CAS  Article  PubMed  PubMed Central  Google Scholar 

Kramer J, Proschak E (2017) Phosphatase activity of soluble epoxide hydrolase. Prostaglandins Other Lipid Mediat 133:88–92. https://doi.org/10.1016/j.prostaglandins.2017.07.002

CAS  Article  PubMed  Google Scholar 

Li PS, Tao W, Yang LQ, Shu YS (2018) Effect of soluble epoxide hydrolase in hyperoxic acute lung injury in mice. Inflammation 41(3):1065–1072. https://doi.org/10.1007/s10753-018-0758-y

CAS  Article  PubMed  Google Scholar 

Meyer NJ, Gattinoni L, Calfee CS (2021) Acute respiratory distress syndrome. Lancet 398(10300):622–637. https://doi.org/10.1016/s0140-6736(21)00439-6

CAS  Article  PubMed  PubMed Central  Google Scholar 

Moher D, Liberati A, Tetzlaff J, Altman DG (2009) Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med 6(7):e1000097. https://doi.org/10.1371/journal.pmed.1000097

Article  PubMed  PubMed Central  Google Scholar 

Nelin LD, Jin Y, Chen B, Liu Y, Rogers LK, Reese J (2022) Cyclooxygenase-2 deficiency attenuates lipopolysaccharide-induced inflammation, apoptosis, and acute lung injury in adult mice. Am J Physiol Regul Integr Comp Physiol 322(2):R126–R135. https://doi.org/10.1152/ajpregu.00140.2021

CAS  Article  PubMed  Google Scholar 

Schmelzer KR, Kubala L, Newman JW, Kim IH, Eiserich JP, Hammock BD (2005) Soluble epoxide hydrolase is a therapeutic target for acute inflammation. Proc Natl Acad Sci U S A 102(28):9772–9777. https://doi.org/10.1073/pnas.0503279102

CAS  Article  PubMed  PubMed Central  Google Scholar 

Shi Z, He Z, Wang DW (2022) CYP450 epoxygenase metabolites, epoxyeicosatrienoic acids, as novel anti-inflammatory mediators. Molecules. https://doi.org/10.3390/molecules27123873

Article  PubMed  PubMed Central  Google Scholar 

Sun CP, Zhang XY, Morisseau C, Hwang SH, Zhang ZJ, Hammock BD, Ma XC (2021) Discovery of soluble epoxide hydrolase inhibitors from chemical synthesis and natural products. J Med Chem 64(1):184–215. https://doi.org/10.1021/acs.jmedchem.0c01507

CAS  Article  PubMed  Google Scholar 

Tao W, Li PS, Yang LQ, Ma YB (2016) Effects of a soluble epoxide hydrolase inhibitor on lipopolysaccharide-induced acute lung injury in mice. PLoS ONE 11(8):e0160359. https://doi.org/10.1371/journal.pone.0160359

CAS  Article  PubMed  PubMed Central  Google Scholar 

Tao W, Li PS, Xu G, Luo Y, Shu YS, Tao YZ, Yang LQ (2018) Soluble epoxide hydrolase plays a vital role in angiotensin II-induced lung injury in mice. Shock 50(5):589–594. https://doi.org/10.1097/shk.0000000000001067

CAS  Article  PubMed  Google Scholar 

Wagner KM, McReynolds CB, Schmidt WK, Hammock BD (2017) Soluble epoxide hydrolase as a therapeutic target for pain, inflammatory and neurodegenerative diseases. Pharmacol Ther 180:62–76. https://doi.org/10.1016/j.pharmthera.2017.06.006

CAS  Article  PubMed  PubMed Central  Google Scholar 

Yang HH, Duan JX, Liu SK, Xiong JB, Guan XX, Zhong WJ, Sun CC, Zhang CY, Luo XQ, Zhang YF, Chen P, Hammock BD, Hwang SH, Jiang JX, Zhou Y, Guan CX (2020) A COX-2/sEH dual inhibitor PTUPB alleviates lipopolysaccharide-induced acute lung injury in mice by inhibiting NLRP3 inflammasome activation. Theranostics 10(11):4749–4761. https://doi.org/10.7150/thno.43108

CAS  Article  PubMed  PubMed Central  Google Scholar 

Zhang YF, Sun CC, Duan JX, Yang HH, Zhang CY, Xiong JB, Zhong WJ, Zu C, Guan XX, Jiang HL, Hammock BD, Hwang SH, Zhou Y, Guan CX (2020) A COX-2/sEH dual inhibitor PTUPB ameliorates cecal ligation and puncture-induced sepsis in mice via anti-inflammation and anti-oxidative stress. Biomed Pharmacother 126:109907. https://doi.org/10.1016/j.biopha.2020.109907

CAS  Article  PubMed  PubMed Central  Google Scholar 

Zhou Y, Liu T, Duan JX, Li P, Sun GY, Liu YP, Zhang J, Dong L, Lee KSS, Hammock BD, Jiang JX, Guan CX (2017) Soluble epoxide hydrolase inhibitor attenuates lipopolysaccharide-induced acute lung injury and improves survival in mice. Shock 47(5):638–645. https://doi.org/10.1097/shk.0000000000000767

CAS  Article  PubMed  PubMed Central  Google Scholar